Skip to site content
U.S. Department of Health and Human Services
Special Diabetes Program for Indians (SDPI)

SDPI Grant Program 2027 Non-Competing Continuation Application

Application Kit Access and Submission

The required method for submission of applications is electronic submission via GrantSolutions. Below are the submission instructions:

  1. Log on to https://www.grantsolutions.gov. Exit Disclaimer: You Are Leaving www.ihs.gov 
  2. Click on “Apply for Non-Competing Award”, this link will be available under “Grants List”
  3. Enter all the application information
  4. After completing all the forms, click on “Verify Submission” to submit the application to IHS.
  5. Click on “Final Submission.”
  6. Click on “OK” upon the prompt “Are you sure you want to submit application?”
  7. You cannot alter any information once the application is submitted.

Contact GrantSolutions Help Desk Exit Disclaimer: You Are Leaving www.ihs.gov  or dgm@ihs.gov with any questions.

What Are You Looking For?

Upcoming SDPI Webinars

Instructions

Application Template and Reports

The following template and reports must be completed, downloaded, and attached to the application kit within GrantSolutions. Review the Instructions and Application Checklist to ensure that you have included all required forms, templates, and other documents in your application kit.

Additional Resources

The following may be helpful in preparing your application:

Application Due Date

The 2027 Continuation Application will be due on or around October 30, 2026. The official due date will be provided in GrantSolutions.

What Comes Next?

All applications will be screened for adherence to the instructions. Applicants who do not submit all required documents in the correct format may be contacted to provide the missing or revised documentation before their application can be reviewed. This may result in a delayed Notice of Award (NoA) and/or Special Grant Conditions on their NoA issuing funds for 2027.

The 2027 continuation application process is not competitive; therefore, applications will not be reviewed by an Objective Review Committee. Instead, the Division of Diabetes program staff or their designees will review them. Approval is dependent on:

  1. Compliance with Terms and Conditions outlined in the 2026 NoA.
  2. Satisfactory business (fiscal) review of the 2027 application.
  3. Satisfactory programmatic review of the 2027 application, including:
    1. Completeness of information from the Project Narrative template.
    2. Submission of baseline data into the SOS
    3. Documented plan for continued work and evaluation in 2027.

Questions?

Include your name, contact information, program name, and grant number when submitting questions.